Valneva to Host Symposium on COVID-19 and Chikungunya globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Everi Digital, the online gaming division of Everi Holdings Inc. (NYSE: EVRI) ("Everi" or the "Company"), a premier provider of land-based and.
Form 6-K Valneva SE For: May 20 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Published: May 20, 2021
in the first quarter of 2021 for:
VLA15, currently the only clinical stage vaccine candidate against Lyme disease
Initiation of additional Phase 2 trial to accelerate pediatric development
VLA2001, currently the only inactivated, adjuvanted vaccine candidate for COVID-19 in clinical trials in Europe:
Initiation of pivotal Phase 3 clinical trial
Participation in the world’s first COVID-19 vaccine booster trial in the UK
Publication of Phase 1/2 results
VLA1553, currently the only Phase 3 chikungunya vaccine program worldwide
Recruitment completion for pivotal Phase 3 trial
Successful Nasdaq listing (Q2 event); $107.6 million of gross proceeds
Cash and cash equivalents of €235.9
million at
31, 2021
Q1 2021 cash and cash equivalents do not include proceeds of $107.6 million from the Company’s recent Global Offering